1652-39-7Relevant articles and documents
INHIBITION OF OLIG2 ACTIVITY
-
Page/Page column 00299-00300, (2019/09/18)
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
Pyrazolopyridine compound and use thereof
-
Paragraph 0476; 0478; 0479, (2018/11/03)
The present invention relates to a pyrazolopyridine compound and use thereof, and further relates to a pharmaceutical composition comprising the pyrazolopyridine compound. The pyrazolopyridine compound or the pharmaceutical composition can be used as a so